Business Wire

Autolus Launches Roadshow for Initial Public Offering

Del

Autolus Therapeutics Limited (to be reorganised as Autolus Therapeutics plc) (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it has begun the roadshow for its initial public offering in the United States of up to 7,812,500 American Depositary Shares (“ADSs”) representing 7,812,500 ordinary shares. The initial public offering price is currently expected to be between $15.00 and $17.00 per ADS, before underwriting discounts and commissions, which would result in an approximate total offering size of between $117.2 million and $132.8 million. Autolus also expects to grant to the underwriters a 30-day option to purchase up to an additional 1,171,875 ADSs at the initial public offering price, less underwriting discounts and commissions. All ADSs to be sold in the proposed offering will be sold by Autolus. Autolus has applied to list its ADSs on The Nasdaq Global Market under the ticker symbol "AUTL."

Goldman Sachs & Co. LLC and Jefferies LLC are acting as joint book-running managers for the offering. Wells Fargo Securities, LLC and William Blair & Company, L.L.C. are acting as lead managers.

The proposed offering will be made only by means of a prospectus. A copy of the preliminary prospectus related to the offering can be obtained from either of the joint book-running managers for the offering, Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at +1 866 471 2526 or by email at prospectusgroup-ny@ny.email.gs.com; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at + 1 877 547 6340, or by email at Prospectus_Department@Jefferies.com. For the avoidance of doubt, such prospectus will not constitute a "prospectus" for the purposes of Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in each relevant EU member state) and will not have been reviewed by any competent authority in any EU member state.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About Autolus

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer cells, break down their defence mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies and solid tumors.

Forward-Looking Statements

This press release contains certain forward-looking statements, including statements with regard to Autolus’ proposed securities offering. Words such as “anticipates,” "believes," “expects,” "intends," "projects," "anticipates," and "future" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that the proposed securities offering discussed above will be consummated on the terms described or at all. Completion of the proposed offering and the terms thereof are subject to numerous factors, many of which are beyond the control of Autolus, including, without limitation, market conditions, failure of customary closing conditions and the risk factors and other matters set forth in Autolus’ filings with the SEC. Autolus undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

###

Summary report:

Litera® Change-Pro for Word 10.1.0.800 Document comparison done on 6/7/2018 2:43:25 PM

Style name: Default Style
Intelligent Table Comparison: Active
Original DMS: iw://NAACTIVE/NAACTIVE/177270164/5
Modified DMS: iw://NAACTIVE/NAACTIVE/177270164/6
Changes:
Add   3

Delete

2
Move From

0

Move To 0
Table Insert 0
Table Delete 0
Table moves to 0
Table moves from 0
Embedded Graphics (Visio, ChemDraw, Images etc.) 0
Embedded Excel 0
Format changes 0
Total Changes: 5

Contact information

Autolus Therapeutics Limited
Investor Contact:
S.A. Noonan Communications, LLC
Susan A Noonan
+1 212 966 3650
susan@sanoonan.com
or
Media Contact:
JW Communications
Julia Wilson
+44 (0)7818 430877
juliawilsonuk@gmail.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Lumileds Wins Jury Verdict of Liability for Intellectual Property Theft Against Elec-Tech International Co., Ltd., Donglei Wang, and Gangyi Chen13.8.2018 22:45Pressemelding

On August 10, 2018, a jury of six men and six women rendered a verdict in favor of one the world’s leading LED companies, Lumileds LLC, based in San Jose, finding that a Chinese competitor stole trade secrets related to Lumileds core technology for making high power LEDs used in flash phones, automotive headlights, and general illumination. The case, Lumileds LLC v. Elec-Tech International Co., Ltd., Donglei “Tony” Wang, and Gangyi Chen, Superior Court of the State of California, County of Santa Clara, found the defendants liable for damages in intellectual property theft. The jury awarded Lumileds $66 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180813005694/en/ Mark Adams, Chief Executive Officer at Lumileds Inc. (Photo: Business Wire) The jury concluded that ETI, Wang and Chen misappropriated Lumileds trade secrets, took them to China, and used them to develop ETI’s LED technology. The award of $66 million is t

Growing Turkish Lira Crisis Drives Investors to Seek Safe Haven in Gold13.8.2018 13:34Pressemelding

The currency crisis engulfing the Turkish Lira is likely to intensify this week as the contagion becomes more widespread around the world. The volatility on the currency exchanges has led investors to pursue the stability offered by safe havens such as gold, which saw a hike in value by 0.4 per cent coinciding with the crash of the Lira. 1 Tom Coughlin, CEO of Kinesis, the bullion backed blockchain monetary system, comments: “The sharp rise in the price of gold seen in the past few days off the back of the Turkish Lira crisis, reflects a rising trend amongst investors wanting to protect their investments, from volatility caused by political instability. This is supplemented by the growing trend of decentralisation which has driven the underlying price of gold up 2% since the start of the year.” Investment in blockchain has doubled in the past year, with 82 per cent of ICO investors citing decentralisation as the main driver behind their investment. 2 Despite this trend, blockchain inve

Seoul Semiconductor’s Innovative SunLike LEDs Earn Industry Recognition in 2018 IES Progress Report13.8.2018 13:00Pressemelding

Seoul Semiconductor (KOSDAQ 046890), a leading global innovator of LED products and technology, has announced that its SunLike Series natural spectrum LEDs, powered by TRI-R, were recognized in the 2018 Illumination Engineering Society (IES) Progress Report, presented on August 10, 2018 at the IES Annual Conference in Boston, MA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180813005229/en/ Seoul Semiconductor’s SunLike was recognized in the 2018 IES Progress Report (Graphic: Business Wire) As the recognized technical and educational authority on illumination, IES annually announces significant new advancements in lighting products, research, publications, and design tools in its IES Progress Report. Acceptance is based on an impartial judging process used by the committee to evaluate each submission on its uniqueness, innovation and significance to the lighting industry. SunLike Series natural spectrum LEDs are the world’

Skunkworks Surfing Co. Co-Founders Appointed to be Endowment for Clean Oceans Judges13.8.2018 11:07Pressemelding

The Endowment for Clean Oceans (ECO) announced that Skunkworks Surfing Co. Co-Founders CEO Chris and Ricky Martin have been selected and they have accepted to be ECO judges. Chris will serve on the Science and Tech Committee, and Ricky on the Entrepreneur Committee. An entrepreneur’s survival depends on their ability to execute their technical vision. “They have the sort of innovative entrepreneur and plastic materials technical expertise we are looking for to be ECO judges,” said Daniel Perrin, Founder and CEO of ECO. The role of the Entrepreneur Committee is to judge each entry to ECO’s two contests for scalability and executability. The Scientific and Technical Committee evaluate each entry from that perspective. “We are extremely excited to be part of this important and historic work,” said the Martin brothers. ECO’s contests are simply to provide a $1 million prize for an actionable and scalable plan to remove the micro and macro pieces of plastic from the ocean, and for the $5 mi

GN Hearing Announces Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution13.8.2018 11:00Pressemelding

GN Hearing today unveils the world’s first Premium-Plus hearing aid: ReSound LiNX Quattro™, designed for people who want the very best that technology has to offer and desire a brilliant sound experience with great speech intelligibility even in noisy situations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180813005254/en/ Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution (Photo: Business Wire) ReSound LiNX Quattro™ offers a new category of hearing solution and expands GN Hearing’s product portfolio, which already includes the premium ReSound LiNX 3D™ product family. Powered by new technology, including a new chip platform, ReSound LiNX Quattro™ offers a combination of unmatched sound quality and rechargeability, while further expanding GN Hearing’s leadership within 2.4 GHz connectivity and remote fine-tuning: Sound quality: A brilliant sound experience, with clearer, fuller a

Calvin Klein Fragrances Releases CALVIN KLEIN WOMEN Global Television Advertising Campaign Featuring Actors Lupita Nyong'o and Saoirse Ronan13.8.2018 11:00Pressemelding

Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. [NYSE: PVH], and Calvin Klein Fragrances, a division of Coty Inc. [NYSE: COTY], today revealed the worldwide television advertising campaign for CALVIN KLEIN WOMEN, the first CALVIN KLEIN fragrance to be developed under the vision of Chief Creative Officer Raf Simons. The campaign features Lupita Nyong'o and Saoirse Ronan. Directed by artist Anne Collier with creative direction from Lloyd & Co., the television campaign unfolds into a series of vignettes that provide a glimpse into Lupita Nyong'o’s and Saoirse Ronan’s creative inspirations. An extension of the print campaign, the commercial follows both women as they reflect on and embrace figures from the past that have inspired them and shaped their identities as women. Viewers see Saoirse playing a Nina Simone record and sharing admiration for Sissy Spacek, while referencing her on the cover of a vintage magazine, while Lupita draws inspiration from beautiful collaged photogr